Reducing the effective dosage of flutamide on prostate cancer cell lines through combination with selenium nanoparticles: An in-vitro study

• Iman Menbari Oskouie,

  Roles Methodology, Writing – original draft

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Fatemeh Khatami,

  Roles Validation

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  https://orcid.org/0000-0002-6311-1336

  ⨯
• Amin Shiralizadeh Dezfuli,

  Roles Validation

  Affiliation Ronash Technology Pars Company (AMINBIC), Tehran University Science and Technology Park, North Campus of Tehran University, Tehran, Iran

  ⨯
• Rahil Mashhadi,

  Roles Resources, Validation

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Akram Mirzaei,

  Roles Methodology, Validation

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Seyedeh Negin Hashemi Dougaheh,

  Roles Methodology, Validation

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Helia Azodian Ghajar,

  Roles Methodology, Validation

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Ramin Heshmat ,

  Roles Formal analysis

  * E-mail: mkaghamir@tums.ac.ir (SMKA); rheshmat@tums.ac.ir (RH)

  Affiliation Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

  ⨯
• Seyed Mohammad Kazem Aghamir

  Roles Conceptualization

  * E-mail: mkaghamir@tums.ac.ir (SMKA); rheshmat@tums.ac.ir (RH)

  Affiliation Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

  https://orcid.org/0000-0003-1611-0362

  ⨯